All countries should offer universal infant immunization against the hepatitis B virus, according to Christopher Mackie, the lead author of a McMaster University public health analysis published in the January 20 issue of the Canadian Medical Association Journal.
Epidemiological studies suggest that roughly one-third of chronic hepatitis B infections are acquired during infancy and early childhood.
In Canada, British Columbia, New Brunswick and Prince Edward Island are the only provinces to offer universal hepatitis B vaccination to infants. The incidence of acute hepatitis B in BC is now consistently below the national average, after years of having a higher incidence rate. Globally, 98% of universal hepatitis B immunization programs are offered in infancy.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze